Variant report
Variant | esv3471526 |
---|---|
Chromosome Location | chr5:17486783-17499009 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:47)
- CpG islands (count:429)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:47 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr5:17492224-17492379 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr5:17486902-17487265 | Hela-S3 | cervix: | n/a | n/a |
3 | CTCF | chr5:17495120-17495270 | Caco-2 | colon: | n/a | n/a |
4 | CTCF | chr5:17491694-17491823 | MCF-7 | breast: | n/a | n/a |
5 | CTCF | chr5:17488800-17488950 | HPF | lung: | n/a | n/a |
6 | CTCF | chr5:17491692-17491836 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | EBF1 | chr5:17490158-17490500 | GM12878 | blood: | n/a | chr5:17490277-17490290 chr5:17490278-17490289 |
8 | EP300 | chr5:17498495-17498839 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr5:17487009-17487549 | Hela-S3 | cervix: | n/a | chr5:17487416-17487425 chr5:17487084-17487098 |
10 | FOSL2 | chr5:17487115-17487592 | A549 | lung: | n/a | chr5:17487130-17487138 chr5:17487131-17487138 chr5:17487415-17487425 chr5:17487415-17487424 chr5:17487416-17487425 |
11 | FOSL2 | chr5:17487168-17487692 | MCF-7 | breast: | n/a | chr5:17487415-17487425 chr5:17487415-17487424 chr5:17487416-17487425 |
12 | GABPA | chr5:17498435-17498852 | Hela-S3 | cervix: | n/a | n/a |
13 | GABPA | chr5:17498469-17498852 | Hela-S3 | cervix: | n/a | n/a |
14 | GATA2 | chr5:17497535-17497893 | SH-SY5Y | brain: | n/a | chr5:17497638-17497654 |
15 | GATA3 | chr5:17487077-17487887 | MCF-7 | breast: | n/a | chr5:17487464-17487472 |
16 | GATA3 | chr5:17487197-17487599 | MCF-7 | breast: | n/a | chr5:17487464-17487472 |
17 | HEY1 | chr5:17498501-17498789 | K562 | blood: | n/a | n/a |
18 | IRF4 | chr5:17498469-17498838 | GM12878 | blood: | n/a | n/a |
19 | IRF4 | chr5:17498490-17498797 | GM12878 | blood: | n/a | n/a |
20 | JUND | chr5:17498564-17498690 | HepG2 | liver: | n/a | n/a |
21 | JUND | chr5:17498570-17498724 | HepG2 | liver: | n/a | n/a |
22 | JUND | chr5:17487152-17487709 | MCF-7 | breast: | n/a | chr5:17487414-17487425 chr5:17487415-17487425 chr5:17487415-17487424 chr5:17487416-17487425 |
23 | JUND | chr5:17487283-17487562 | HepG2 | liver: | n/a | chr5:17487414-17487425 chr5:17487415-17487425 chr5:17487415-17487424 chr5:17487416-17487425 |
24 | JUND | chr5:17487102-17487627 | Hela-S3 | cervix: | n/a | chr5:17487130-17487138 chr5:17487131-17487138 chr5:17487414-17487425 chr5:17487415-17487425 chr5:17487415-17487424 chr5:17487416-17487425 |
25 | MAZ | chr5:17494440-17494508 | HepG2 | liver: | n/a | n/a |
26 | PAX5 | chr5:17498317-17498857 | GM12878 | blood: | n/a | n/a |
27 | POLR2A | chr5:17492452-17492655 | ProgFib | skin: | n/a | n/a |
28 | POLR2A | chr5:17491576-17491721 | MCF-7 | breast: | n/a | n/a |
29 | POLR2A | chr5:17486712-17486833 | MCF-7 | breast: | n/a | n/a |
30 | POLR2A | chr5:17493734-17493799 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr5:17495145-17495223 | K562 | blood: | n/a | n/a |
32 | POU2F2 | chr5:17498419-17498798 | GM12878 | blood: | n/a | n/a |
33 | RAD21 | chr5:17487111-17487475 | Hela-S3 | cervix: | n/a | n/a |
34 | SIN3AK20 | chr5:17498590-17498688 | HepG2 | liver: | n/a | n/a |
35 | SIX5 | chr5:17498434-17498727 | K562 | blood: | n/a | n/a |
36 | STAT3 | chr5:17489720-17489739 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | TCF3 | chr5:17498507-17498884 | GM12878 | blood: | n/a | n/a |
38 | TCF7L2 | chr5:17490750-17490765 | Hela-S3 | cervix: | n/a | n/a |
39 | TEAD4 | chr5:17496327-17496750 | H1-hESC | embryonic stem cell: | n/a | chr5:17496534-17496543 |
40 | TEAD4 | chr5:17496351-17496698 | H1-hESC | embryonic stem cell: | n/a | chr5:17496534-17496543 |
41 | USF1 | chr5:17498590-17498699 | HepG2 | liver: | n/a | n/a |
42 | ZBTB33 | chr5:17498438-17498852 | K562 | blood: | n/a | n/a |
43 | ZBTB33 | chr5:17498517-17498854 | GM12878 | blood: | n/a | n/a |
44 | ZBTB33 | chr5:17498583-17498697 | HepG2 | liver: | n/a | n/a |
45 | ZBTB33 | chr5:17498349-17498817 | GM12878 | blood: | n/a | n/a |
46 | ZBTB33 | chr5:17498426-17498894 | K562 | blood: | n/a | n/a |
47 | ZNF384 | chr5:17495251-17495451 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:17491469-17491519 | HCT-116 | colon: | n/a |
2 | chr5:17491604-17491654 | ProgFib | skin: | n/a |
3 | chr5:17491469-17491519 | HCT-116 | colon: | n/a |
4 | chr5:17491604-17491654 | ProgFib | skin: | n/a |
5 | chr5:17491604-17491654 | U87 | brain: | n/a |
6 | chr5:17495781-17495831 | GM12891 | blood: | n/a |
7 | chr5:17490778-17490828 | MCF10A-Er-Src | breast: | n/a |
8 | chr5:17491469-17491519 | HRCEpiC | kidney: | n/a |
9 | chr5:17491469-17491519 | AoSMC | blood vessel: | n/a |
10 | chr5:17491586-17491636 | H1-hESC | embryonic stem cell: | embryo |
11 | chr5:17490778-17490828 | PANC-1 | pancreas: | n/a |
12 | chr5:17491469-17491519 | SK-N-MC | brain: | n/a |
13 | chr5:17491586-17491636 | K562 | blood: | n/a |
14 | chr5:17491469-17491519 | T-47D | breast: | n/a |
15 | chr5:17491604-17491654 | HCF | heart: | n/a |
16 | chr5:17491604-17491654 | Hepatocyte | liver: | n/a |
17 | chr5:17491469-17491519 | HPAEpiC | pulmonary alveolar: | n/a |
18 | chr5:17491941-17491991 | ovcar-3 | ovarian: | n/a |
19 | chr5:17488879-17488929 | GM12891 | blood: | n/a |
20 | chr5:17491469-17491519 | CMK | blood: | n/a |
21 | chr5:17495781-17495831 | BE2_C | brain: | n/a |
22 | chr5:17490778-17490828 | SK-N-MC | brain: | n/a |
23 | chr5:17491586-17491636 | HepG2 | liver: | n/a |
24 | chr5:17495781-17495831 | Jurkat | blood: | n/a |
25 | chr5:17491941-17491991 | T-47D | breast: | n/a |
26 | chr5:17495781-17495831 | K562 | blood: | n/a |
27 | chr5:17488879-17488929 | HEK293 | kidney: | embryo |
28 | chr5:17495781-17495831 | IMR90 | lung: | fetal |
29 | chr5:17491941-17491991 | GM12878 | blood: | n/a |
30 | chr5:17491941-17491991 | GM19239 | blood: | n/a |
31 | chr5:17490778-17490828 | HMEC | breast: | n/a |
32 | chr5:17491941-17491991 | RPTEC | kidney: | n/a |
33 | chr5:17490778-17490828 | HEEpiC | esophagus: | n/a |
34 | chr5:17491586-17491636 | NT2-D1 | testis: | n/a |
35 | chr5:17491604-17491654 | HAEpiC | amniotic membrane: | n/a |
36 | chr5:17491604-17491654 | HRE | kidney: | n/a |
37 | chr5:17488879-17488929 | HCPEpiC | choroid plexus: | n/a |
38 | chr5:17491941-17491991 | LNCaP | prostate: | n/a |
39 | chr5:17495781-17495831 | Hepatocyte | liver: | n/a |
40 | chr5:17491586-17491636 | NH-A | brain: | n/a |
41 | chr5:17490778-17490828 | HRPEpiC | eye: | n/a |
42 | chr5:17491604-17491654 | MCF10A-Er-Src | breast: | n/a |
43 | chr5:17491586-17491636 | SK-N-SH_RA | brain: | n/a |
44 | chr5:17491604-17491654 | HNPCEpiC | eye: | n/a |
45 | chr5:17491469-17491519 | HEEpiC | esophagus: | n/a |
46 | chr5:17491941-17491991 | HCF | heart: | n/a |
47 | chr5:17488879-17488929 | H1-hESC | embryonic stem cell: | embryo |
48 | chr5:17491941-17491991 | AG04450 | lung: | fetal |
49 | chr5:17491604-17491654 | K562 | blood: | n/a |
50 | chr5:17491604-17491654 | GM12891 | blood: | n/a |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-BASP1-11 | chr5:17494578-17494846 | l_2885_chr5:17456969-17494846_brain |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000250667 | TF binding region |
ENSG00000268799 | TF binding region |
ENSG00000185041 | TF binding region |
ENSG00000250667 | CpG island |
ENSG00000268799 | CpG island |
ENSG00000185041 | CpG island |
ENSG00000250667 | chromatin interactions |
ENSG00000268799 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs61748308 | chr5:17486783-17486784 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs61748309 | chr5:17486788-17486789 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs201910172 | chr5:17486824-17486825 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546606995 | chr5:17486839-17486840 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs200505938 | chr5:17486841-17486842 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541830986 | chr5:17486847-17486848 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs191192792 | chr5:17486848-17486849 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552455649 | chr5:17486879-17486880 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs569475891 | chr5:17486880-17486881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538155264 | chr5:17486900-17486901 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555330932 | chr5:17486952-17486953 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575225484 | chr5:17486977-17486978 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs536225837 | chr5:17487023-17487024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs553007509 | chr5:17487080-17487081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs183394473 | chr5:17487100-17487101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187689135 | chr5:17487108-17487109 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564926698 | chr5:17487116-17487117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575422231 | chr5:17487117-17487118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544161346 | chr5:17487220-17487221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560817299 | chr5:17487247-17487248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112635888 | chr5:17487270-17487271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563122971 | chr5:17487314-17487315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546545661 | chr5:17487323-17487324 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs560123573 | chr5:17487336-17487337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs114989188 | chr5:17487351-17487352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs367831071 | chr5:17487410-17487411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs552687266 | chr5:17487528-17487529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs569332431 | chr5:17487532-17487533 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538398874 | chr5:17487537-17487538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531323658 | chr5:17487569-17487570 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs370603797 | chr5:17487625-17487626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs141142485 | chr5:17487641-17487642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192753160 | chr5:17487645-17487646 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs552991557 | chr5:17487689-17487690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184160265 | chr5:17487691-17487692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs538331306 | chr5:17487696-17487697 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs558651712 | chr5:17487697-17487698 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575261192 | chr5:17487699-17487700 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543976913 | chr5:17487704-17487705 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs34893807 | chr5:17487731-17487732 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs560754438 | chr5:17487739-17487740 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs150912204 | chr5:17487749-17487750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs540176214 | chr5:17487767-17487768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs560111396 | chr5:17487771-17487772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs532567804 | chr5:17487795-17487796 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs113978148 | chr5:17487802-17487803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs188410832 | chr5:17487899-17487900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144034988 | chr5:17487950-17487951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs372292246 | chr5:17487975-17487976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs549847101 | chr5:17487977-17487978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 21364760 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Acute lymphoblastic leukemia | 17640729 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Lung cancer | 16740712 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Melanoma | 22183965 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Autism | 19287141 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:17483000-17487000 | Weak transcription | A549 | lung |
2 | chr5:17486200-17487800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr5:17487000-17487600 | Enhancers | A549 | lung |
4 | chr5:17487200-17487400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr5:17487200-17487600 | Enhancers | Hela-S3 | cervix |
6 | chr5:17487400-17488200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr5:17488200-17489000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr5:17494400-17496200 | Enhancers | Primary neutrophils fromperipheralblood | blood |